How the Legal System Can Help Create a Recovery Culture in Mental Health Systems
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Suggestions to the Human Rights Committee for Disability-Related Questions to Consider for Its List of Issues for the United States
Center for the Human Rights of Users and Survivors of Psychiatry1 Repeal Mental Health Laws Documenting and challenging forced psychiatric treatment Suggestions to the Human Rights Committee for disability-related questions to consider for its List of Issues for the United States The situation of people labeled with psychiatric disabilities in the United States raises questions under Articles 2, 6, 7, 9, 10, 16, 25 and 26 of the Covenant. We use the term “people labeled with psychiatric disabilities” to refer to those who identify as having experienced madness, mental health problems or trauma, or as having been labeled with a psychiatric diagnosis. These individuals are covered as persons with disabilities under the Americans with Disabilities Act2 and under the United Nations Convention on the Rights of Persons with Disabilities.3 “From Privileges to Rights: People Labeled with Psychiatric Disabilities Speak for Themselves” was the title of a significant report issued in January 2000 by the U.S. National Council on Disability.4 We consider the “medical model of mental health,” under which altered mental and emotional states are characterized as pathological medical conditions, to be incompatible with our human rights and dignity. The Committee on the Rights of Persons with Disabilities acknowledges that alternatives to the medical model of mental health, including peer support, need to be made available.5 This submission suggests questions to ask of the United States government, followed by a preliminary review of the current state of U.S. laws and practices. 1 For information on organizations submitting this report see Annex I. 2 42 USC chapter 126; see § 12102 Definition of disability. -
United for a Revolution in Mental Health Care
Winter 2009-10 www.MindFreedom.org Protesters give a Mad Pride injection to the psychiatric industry directly outside the doors of the American Psychiatric Association Annual Meeting during a “Festival of Resistance” co-sponsored by MindFreedom International and the California Network of Mental Health Clients. See page 8 for more. Victory! MindFreedom Helps Ray Sandford Stop His Forced Electroshock Mad Pride in Media Launched: Directory of Alternative Mental Health Judi Chamberlin Leads From Hospice United for a Revolution in Mental Health Care www.MindFreedom.org Published PbyAGE MFI • MindFreedom International Wins Campaigns for Human Rights and From the Executive Director: Everyone Has Something To Offer Alternatives in the Mental Health System Please join! BY DAVID W. OAKS all psychiatric oppression “BY This is a TUESDAY.” MindFreedom International Sponsor Group or Affiliate has a Because of generous support from place where www.MindFreedom.org (MFI) is one of the few groups liaison on the MFI Support Coalition MindFreedom groups and members, “So,” Judi said, “that’s what I MindFreedom in the mental health field that is Advisory Council. [email protected] in the last few months I have had want. By Tuesday.” members can post to forums independent with no funding from MFI’s mission: “In a spirit of the privilege of visiting MindFree- In that spirit, here are some tips for and blogs that are or links to governments, mental mutual cooperation, MindFreedom MindFreedom International dom International (MFI) activists in our members in effective leadership open to public health providers, drug companies, International leads a nonviolent 454 Willamette, Suite 216 Norway, Maine, Massachusetts, Min- in MindFreedom International, for a view. -
Pursuing Wellness Through Recovery and Integration
FOR THE PROGRAM IPS 2012 Pursuing Wellness Through Recovery and Integration American Psychiatric Association 64TH INSTITUTE ON PSYCHIATRIC SERVICES NEW YORK CITY, OCTOBER 4–7 © JP Laffont/Sygma/Corbis 64th Institute on Psychiatric Services APA’s Leading Educational Conference on Public, Community, and Clinical Psychiatry Table OF Contents Table of Contents ������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������� 1 Scientific Program Committee and APA Officers and Staff �����������������������������������������������������������������������������������������������2–3 Key Locations at the Sheraton New York Hotel & Towers ����������������������������������������������������������������������������������������������������� 4 Educational Objectives �������������������������������������������������������������������������������������������������������������������������������������������������������������������������� 4 Target Audiences �������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������� 4 Evaluation of the Institute on Psychiatric Services �������������������������������������������������������������������������������������������������������������������� 4 CME Certificate of Attendance Booth Hours ����������������������������������������������������������������������������������������������������������������������������� -
Antipsychiatry Movement 29 Wikipedia Articles
Antipsychiatry Movement 29 Wikipedia Articles PDF generated using the open source mwlib toolkit. See http://code.pediapress.com/ for more information. PDF generated at: Mon, 29 Aug 2011 00:23:04 UTC Contents Articles Anti-psychiatry 1 History of anti-psychiatry 11 Involuntary commitment 19 Involuntary treatment 30 Against Therapy 33 Dialectics of Liberation 34 Hearing Voices Movement 34 Icarus Project 45 Liberation by Oppression: A Comparative Study of Slavery and Psychiatry 47 MindFreedom International 47 Positive Disintegration 50 Radical Psychology Network 60 Rosenhan experiment 61 World Network of Users and Survivors of Psychiatry 65 Loren Mosher 68 R. D. Laing 71 Thomas Szasz 77 Madness and Civilization 86 Psychiatric consumer/survivor/ex-patient movement 88 Mad Pride 96 Ted Chabasinski 98 Lyn Duff 102 Clifford Whittingham Beers 105 Social hygiene movement 106 Elizabeth Packard 107 Judi Chamberlin 110 Kate Millett 115 Leonard Roy Frank 118 Linda Andre 119 References Article Sources and Contributors 121 Image Sources, Licenses and Contributors 123 Article Licenses License 124 Anti-psychiatry 1 Anti-psychiatry Anti-psychiatry is a configuration of groups and theoretical constructs that emerged in the 1960s, and questioned the fundamental assumptions and practices of psychiatry, such as its claim that it achieves universal, scientific objectivity. Its igniting influences were Michel Foucault, R.D. Laing, Thomas Szasz and, in Italy, Franco Basaglia. The term was first used by the psychiatrist David Cooper in 1967.[1] Two central contentions -
Psychiatric Medication Withdrawal
JHPXXX10.1177/0022167818765331Journal of Humanistic PsychologyHall 765331research-article2018 Special Issue: Humanistic Perspectives on Understanding and Responding to Extreme States Journal of Humanistic Psychology 1 –10 Psychiatric Medication © The Author(s) 2018 Reprints and permissions: Withdrawal: Survivor sagepub.com/journalsPermissions.nav https://doi.org/10.1177/0022167818765331DOI: 10.1177/0022167818765331 Perspectives and journals.sagepub.com/home/jhp Clinical Practice Will Hall1 Abstract As patient/survivor movements continue to challenge reductionist biological views mental health and psychosis, there is rising skepticism toward psychiatric medications and growing interest in withdrawal and alternatives. This new perspective also calls for a rethinking of reductionist assumptions about psychiatric medications themselves. General medical patient experience with collaborative decision making for other conditions has broad implications for psychiatric drug withdrawal, and by recognizing psychiatric medications as psychoactive substances, addiction science also suggests a central role for social context and therapeutic common factors in medication withdrawal response. New understandings of madness and medications support an emerging reconsideration of what constitutes the very definition of “health,” where measuring the absence of disease symptoms gives way to a systems-based focus on self-management, social relationships, and adaptability. Keywords collaboration, DSM, mental disorder, psychiatric drugs, psychiatry, psychotherapy, qualitative research, schizophrenia, therapeutic relationship, psychosis 1Maastricht University MHeNS School for Mental Health and Neuroscience, Maastricht, Netherlands Corresponding Author: Will Hall, c/o 1017 Ashmount Avenue, Oakland, CA 94610, USA. Email: [email protected] 2 Journal of Humanistic Psychology 00(0) Emerging research urges greater caution in psychiatric medication treatment, including for psychotic disorders where medications have been considered indispensable (Murray et al., 2016). -
HB-05298 Mendelsohn, Stephen
Stephen Mendelsohn 171 Hartford Road, #19 New Britain, CT 06053-1532 [email protected] Testimony in support of HB 5298, An Act Concerning Involuntary Shock Therapy Senator Gerratana, Rep. Johnson, and members of the Public Health Committee: As a psychiatric survivor and member of Second Thoughts Connecticut, I strongly support HB 5298, An Act Concerning Involuntary Shock Therapy. This bill seeks to protect the right of people to say no to electroshock, a controversial and brain-disabling psychiatric intervention. While I have never had electroshock or insulin coma, being mislabeled "paranoid schizophrenic" and coerced into taking disabling neuroleptic drugs was horrible enough. HB 5298 is a modest bill. It does not ban electroshock, as the voters of Berkeley, CA did in a 1982 ballot referendum that passed with nearly 62% of the vote. The National Council on Disability, which Cathy Ludlum will cite in her testimony, has also taken a position against electroshock as a treatment modality (in addition to opposing forced treatment generally). According to an NCD report, "Public policy should move toward the elimination of electroconvulsive therapy and psychosurgery as unproven and inherently inhumane procedures." What we should strive for is fully informed, uncoerced consent. Unfortunately, institutional psychiatry is riddled with force, coercion, and deception, making truly informed consent difficult, if not nearly impossible. One cannot give informed consent to ECT if one is being threatened with involuntary commitment or forced drugging for refusing to sign the consent form. I would therefore urge you to consider strengthening this legislation by requiring "written informed, uncoerced consent" in section 17a-543 of the Connecticut General Statutes. -
Before We Begin, I Would Now Like to Ask Our Distinguished
1 UNITED STATES OF AMERICA DEPARTMENT OF HEALTH AND HUMAN SERVICES FOOD AND DRUG ADMINISTRATION + + + CENTER FOR DEVICES AND RADIOLOGICAL HEALTH MEDICAL DEVICES ADVISORY COMMITTEE + + + NEUROLOGICAL DEVICES PANEL + + + January 27, 2011 9:00 a.m. Hilton Washington DC North 620 Perry Parkway Gaithersburg, Maryland PANEL MEMBERS: THOMAS G. BROTT, M.D. Temporary Non-Voting Chair KAREN E. ANDERSON, M.D. Temporary Non-Voting Member KAREN B. DOMINO, M.D., M.P.H. Temporary Non-Voting Member KEVIN DUFF, Ph.D. Temporary Non-Voting Member JONAS H. ELLENBERG, Ph.D. Temporary Non-Voting Member DAVID C. GOOD, M.D. Temporary Non-Voting Member WAYNE K. GOODMAN, M.D. Temporary Non-Voting Member MAE O. GORDON, Ph.D. Temporary Non-Voting Member SCOTT Y.H. KIM, M.D. Temporary Non-Voting Member WILLIAM M. McDONALD, M.D. Temporary Non-Voting Member JANE S. PAULSEN, Ph.D. Temporary Non-Voting Member GUERRY M. PEAVY, Ph.D. Temporary Non-Voting Member CHRISTOPHER A. ROSS, M.D., Ph.D. Temporary Non-Voting Member GLENN T. STEBBINS, Ph.D. Temporary Non-Voting Member ANDREW WINOKUR, M.D., Ph.D. Temporary Non-Voting Member E. FRANCINE STOKES McELVEEN, J.D., M.S. Consumer Representative DAVID H. MUELLER, M.S. Industry Representative MICHELLE CARRAS Patient Representative OLGA I. CLAUDIO, Ph.D. Designated Federal Officer Free State Reporting, Inc. 1378 Cape Saint Claire Road Annapolis, MD 21409 (410) 974-0947 2 FDA REPRESENTATIVES: MALVINA B. EYDELMAN, M.D. Director, Division of Ophthalmic, Neurological and Ear, Nose and Throat Devices, Office of Device Evaluation GERETTA WOOD Director, Advisory Committee Program SANDY WALSH Press Contact FDA PRESENTERS: MARJORIE SHULMAN Program Operations Staff, Office of Device Evaluation LCDR BRADLEY CUNNINGHAM CDRH/ODE/DONED ANNA GEORGIOPOULOS, M.D. -
The Electroshock Quotationary®
The Electroshock Quotationary® Leonard Roy Frank, Editor Publication date: June 2006 Copyright © 2006 by Leonard Roy Frank. All Rights Reserved. Dedicated to everyone committed to ending the use of electroshock everywhere and forever The Campaign for the Abolition of Electroshock in Texas (CAEST) was founded in Austin during the summer of 2005. The Electroshock Quotationary (ECTQ) was created to support the organization’s opposition to electroshock by informing the public, through CAEST’s website, about the nature of electroshock, its history, why and how it’s used, its effects on people, and the efforts to promote and stop its use. The editor plans to regularly update ECTQ with suitable materials when he finds them or when they are brought to his attention. In this regard he invites readers to submit original and/or published materials for consideration (e-mail address: [email protected]). CONTENTS Acknowledgements Introduction: The Essentials (7 pages) Text: Chronologically Arranged Quotations (146 pages) About the Editor ACKNOWLEDGEMENTS For their many kindnesses, contributions and suggestions to The Electroshock Quotationary, I am most grateful to Linda Andre, Ronald Bassman, Margo Bouer, John Breeding, Doug Cameron, Ted Chabasinski, Lee Coleman, Alan Davisson, Dorothy Washburn Dundas, Sherry Everett, John Friedberg, Janet Gotkin, Ben Hansen, Wade Hudson, Juli Lawrence, Peter Lehmann, Diann’a Loper, Rosalie Maggio, Jeffrey Moussaieff Masson, Carla McKague, Jim Moore, Bob Morgan, David Oaks, Una Parker, Marc Rufer, Sherri Schultz, Eileen Walkenstein, Ann Weinstock, Don Weitz, and Rich Winkel. INTRODUCTION: THE ESSENTIALS I. THE CONTROVERSY Electroshock (also known as shock therapy, electroconvulsive treatment, convulsive therapy, ECT, EST, and ECS) is a psychiatric procedure involving the induction of a grand mal seizure, or convulsion, by passing electricity through the brain. -
Potential Conflicts of Interest Between Ect Researchers, Ect Device Manufacturers, Fda/Nimh
POTENTIAL CONFLICTS OF INTEREST BETWEEN ECT RESEARCHERS, ECT DEVICE MANUFACTURERS, FDA/NIMH In 1985, NIMH used federal funds to pay for a “Consensus Conference on ECT”— organized by the American Psychiatric Association (APA), with the planning committee consisting of psychiatrists with long-standing financial relationships to the Electroconvulsive Therapy (ECT) device manufacturers. The two U.S. ECT device manufacturers are MECTA and Somatics, Inc. Between 1999 and 2009, NIMH provided more than $23.7 million of taxpayer money for grants for ECT research, including to those sitting on the APA ECT Task Forces.1 The FDA has relied, in part, upon APA ECT Task Force reports, which since 1978 have been prepared by committees whose members include psychiatrists with conflicts of interest with ECT device manufacturers. In 2010, DR. LAWRENCE PARK, FDA medical officer, co-wrote the FDA’s Executive Summary on ECT. He is a psychiatrist who has co-authored numerous studies on ECT.2 Before he joined the FDA, he served as the Director of Research and Attending Psychiatrist for the Somatic Therapies Unit at Massachusetts General Hospital, where ECT is administered.3 Its website states ECT does not cause brain damage and is a safe and relatively comfortable experience—contrary to thousands of ECT “consumers” who presented comments to the FDA stating the opposite.4 MECTA’s submission to the FDA in 2010 cited 18 studies by Harold Sackeim, Ph.D., 13 by Dr. Richard Weiner and 8 by Dr. Andrew Krystal—all of whom have conflicts of interest with MECTA and/or Somatics, Inc.5 Each has been a member of an APA ECT Task Force, with Dr. -
An Analysis of Psychologist Postdoctoral Psychopharmacology
Antioch University AURA - Antioch University Repository and Archive Student & Alumni Scholarship, including Dissertations & Theses Dissertations & Theses 2016 An Analysis of Psychologist Postdoctoral Psychopharmacology Training Materials for Critiques of Neurobiological Hypotheses of Depression's Etiology, Critical Analyses of the DSM's Rigor, and for Consumer/Survivor/Ex- Patient Content. Chris William Nicholas Rowe Antioch University Seattle Follow this and additional works at: http://aura.antioch.edu/etds Part of the Educational Assessment, Evaluation, and Research Commons, Other Pharmacy and Pharmaceutical Sciences Commons, and the Psychology Commons Recommended Citation Rowe, Chris William Nicholas, "An Analysis of Psychologist Postdoctoral Psychopharmacology Training Materials for Critiques of Neurobiological Hypotheses of Depression's Etiology, Critical Analyses of the DSM's Rigor, and for Consumer/Survivor/Ex-Patient Content." (2016). Dissertations & Theses. 305. http://aura.antioch.edu/etds/305 This Dissertation is brought to you for free and open access by the Student & Alumni Scholarship, including Dissertations & Theses at AURA - Antioch University Repository and Archive. It has been accepted for inclusion in Dissertations & Theses by an authorized administrator of AURA - Antioch University Repository and Archive. For more information, please contact [email protected], [email protected]. AN ANALYSIS OF PSYCHOLOGIST POSTDOCTORAL PSYCHOPHARMACOLOGY TRAINING MATERIALS FOR CRITIQUES OF NEUROBIOLOGICAL HYPOTHESES OF DEPRESSION’S -
Dangerous Gifts: Towards a New Wave of Mad Resistance
Dangerous Gifts: Towards a New Wave of Mad Resistance Jonah Bossewitch Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy under the Executive Committee of the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2016 ©2016 Jonah Bossewitch All rights reserved ABSTRACT Dangerous Gifts: Towards a New Wave of Mad Resistance Jonah Bossewitch This dissertation examines significant shifts in the politics of psychiatric resistance and mental health activism that have appeared in the past decade. This new wave of resistance has emerged against the backdrop of an increasingly expansive diagnostic/treatment para- digm, and within the context of activist ideologies that can be traced through the veins of broader trends in social movements. In contrast to earlier generations of consumer/survivor/ex-patient activists, many of whom dogmatically challenged the existence of mental illness, the emerging wave of mad activists are demanding a voice in the production of psychiatric knowledge and greater control over the narration of their own identities. After years as a participant-observer at a leading radical mental health advocacy organization, The Icarus Project, I present an ethnography of conflicts at sites including Occupy Wall Street and the DSM-5 protests at the 2012 American Psychiatric Association conference. These studies bring this shift into focus, demonstrate how non-credentialed stakehold- ers continue to be silenced and marginalized, and help us understand the complex ideas these activists are expressing. This new wave of resistance emerged amidst a revolution in communication technologies, and throughout the dissertation I consider how activists are utilizing communications tools, and the ways in which their politics of resistance res- onate deeply with the communicative modalities and cultural practices across the web. -
Maastricht Survey Progress Report January 2020
SEPT. 11 2019 PROGRESS REPORT MAASTRICHT WORLD SURVEY ON ANTIPSYCHOTIC DRUG WITHDRAWAL WILL HALL, MAASTRICHT UNIVERSITY SCHOOL FOR MENTAL HEALTH AND NEUROSCIENCE [email protected] WORLD SURVEY ON ANTIPSYCHOTIC DRUG WITHDRAWAL INTRODUCTION ▸ Last year I (Will Hall) launched an online survey for the Maastricht World Study on Antipsychotic Medication Withdrawal. The study is for my PhD research at Maastricht University School for Mental Health and Neuroscience in the Netherlands, begun in 2016 and supervised by Dr. Jim van Os. ▸ Research on antipsychotic withdrawal brings together 15 years of experience working in the field, as well as my personal experiences as a schizophrenia diagnosis survivor, and reflects the collaboration of many user- survivor colleagues and allies over the years. ▸ I receive no funding for this research; my income is from my private practice as a therapist and as a training consultant. I also devote considerable time to community development work around mental health. So bear with me as the study proceeds at a more modest pace! WORLD SURVEY ON ANTIPSYCHOTIC DRUG WITHDRAWAL THANKS AND ACKNOWLEDGEMENTS ▸ This work has been an unpaid part of my PhD studies at Maastricht University. I have Translation Marian Goldstein greatly benefitted from the assistance and Radoslaw Stupak support of many collaborators since Joana Crawford Masami Glines inception, and I’m grateful for their Laura van Os contributions and guidance: Jade Bertaud Chiara Forzi Study Committee Feedback Recruitment Christian Rauschenberg Jim